Nuffield council on bioethics consultation

Pharmacogenomics

Volumn 4, Issue 1, 2003, Pages 91-95

  Lipton, Peter ^a  

^a NONE

Author keywords

Consultation; Ethics; Genetics variation; Medicine; Pharmacogenetics; Regulation

Indexed keywords

CYTOCHROME P450 2D6; DRUG; ONCOPROTEIN; TRASTUZUMAB;

ARTICLE; BREAST CANCER; DOCUMENTATION; DRUG EFFICACY; DRUG RESEARCH; DRUG RESPONSE; DRUG SAFETY; ETHICS; GENETIC ANALYSIS; HUMAN; LEGAL ASPECT; MEDICAL GENETICS; PHARMACOGENETICS; PRESCRIPTION; SIDE EFFECT; SOCIAL ASPECT;

EID: 0037232253     PISSN: 14622416     EISSN: None     Source Type: Journal    
DOI: 10.1517/phgs.4.1.91.22585     Document Type: Article

References (3)

1. See for example Genetic Screening (Nuffield Council on Bioethics, 1993) and Inside Information (Human Genetics Commission, 2002).
2. Robertson JA: Consent and privacy in pharmacogenetic testing. Nat. Genetics 28, 207 (2001).
3. Position Paper on Terminology in Pharmacogenetics by EMEA/CPMP (December 2001).